©Celoxica 2008. T: +44 (0)1235 863656
Investor relations
The information in this part of the website is being disclosed for the purposes of Rule 26 of the AIM Rules for Companies.
Celoxica is at the forefront of accelerated computing solutions.
"The initial feedback from the market is very encouraging with one US-based trading group describing our solution and bench market results as ‘game changing’. And I think that sums up the new Celoxica pretty well.”
Lee Staines, CEO
Our focus is on addressing some of the most challenging problems facing the finance sector, such as the exponential development of electronic trading and growth of complex derivatives trading, where we can deliver advantage measured in microseconds.
There is a rising demand for accelerated solutions within investment banks, market data providers and exchanges which is a good match with the low-latency and high bandwidth solutions that Celoxica provides.
The need for speed is vital, but so too is the need for efficiency and a green IT approach in the data centre. Celoxica’s high speed and low-latency help to redress the balance of data volumes outstripping advances in CPU processing speeds; and our very low power/cooling needs are kind to the environment.
Headquartered in Abingdon, Oxfordshire and New York, Celoxica is a public company quoted on AIM at the London Stock Exchange.
Celoxica is incorporated in and its main country of operation is the UK with offices in Abingdon and New York.
Corporate Information
Registered Offices |
Investor Contacts |
|---|---|
Celoxica Holdings plc |
Michelle Young (CFO) |
Financial Calendar
| Date |
|
|---|---|
Next year end to be reported: |
31 December 2007 |
Next prelim announcement: |
T.B.A. |
Next annual report due: |
T.B.A. |
Next AGM: |
T.B.A. |
Next interim announcement: |
T.B.A. |
Investor Relations section last updated 29th April 2008
